First, its important to have a basic understanding of how these medicines work
Ajabnoor GMA, Hashim KT, Alzahrani MM, Alsuheili AZ, Alharbi AF, Alhozali AM, Enani S, Eldakhakhny B, Elsamanoudy A (2023) The possible effect of the long-term use of glucagon-like peptide-1 receptor agonists (GLP-1RA) on Hba1c and lipid profile in type 2 diabetes mellitus: a retrospective study in KAUH, Jeddah, Saudi Arabia
Clinical data show that GLP-1 users usually regain weight without continued use, though people who lose more at first keep more off long-term (ending 12% lighter)
This might be a deciding factor if youre eager to start your weight-loss program
The most significant weight loss window occurs between months two and four, when the medication reaches therapeutic dose levels